Retatrutide 40mg pen (R&D Only)

£69.99

Retatrutide 40mg pen is a search term associated with an investigational compound being studied for its activity at GIP, GLP-1 and glucagon receptors. Explore its research background, clinical development, safety considerations and UK regulatory status.

For general weight-management information, see the Alluvi Healthcare Weight Loss category. This is an informational reference only and does not indicate that retatrutide is an authorised UK treatment.

Retatrutide is investigational and is not authorised as a routine UK medicine.

Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,